SMTL ID : 4qfr.2 (2 other biounits)

Structure of AMPK in complex with Cl-A769662 activator and STAUROSPORINE inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.34 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x STU: STAUROSPORINE(Non-covalent)

STU.1: 21 residues within 4Å: Chain A: L.24, G.25, V.26, G.27, V.32, A.45, K.47, I.79, M.95, E.96, Y.97, V.98, S.99, G.101, E.102, E.145, N.146, L.148, A.158, D.159 Ligands: CL.5 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.24, A:V.32, A:A.45, A:Y.97, A:E.102, A:L.148, A:L.148 Hydrogen bonds: A:E.96, A:V.98, A:E.145 STU.12: 21 residues within 4Å: Chain D: L.24, G.25, V.26, G.27, V.32, A.45, K.47, I.79, M.95, E.96, Y.97, V.98, S.99, G.101, E.102, E.145, N.146, L.148, A.158, D.159 Ligands: CL.16 11 PLIP interactions: 11 interactions with chain D Hydrophobic interactions: D:L.24, D:V.32, D:A.45, D:Y.97, D:E.102, D:L.148, D:L.148 Hydrogen bonds: D:E.96, D:V.98, D:E.102, D:E.145

10 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: S.99, A.151 Ligand excluded by PLIP CL.3: 2 residues within 4Å: Chain A: K.36, K.43 Ligand excluded by PLIP CL.4: 1 residues within 4Å: Chain A: G.212 Ligand excluded by PLIP CL.5: 4 residues within 4Å: Chain A: G.25, V.26, G.27 Ligands: STU.1 Ligand excluded by PLIP CL.7: 2 residues within 4Å: Chain B: T.19, D.70 Ligand excluded by PLIP CL.13: 2 residues within 4Å: Chain D: S.99, A.151 Ligand excluded by PLIP CL.14: 2 residues within 4Å: Chain D: K.36, K.43 Ligand excluded by PLIP CL.15: 1 residues within 4Å: Chain D: G.212 Ligand excluded by PLIP CL.16: 4 residues within 4Å: Chain D: G.25, V.26, G.27 Ligands: STU.12 Ligand excluded by PLIP CL.18: 2 residues within 4Å: Chain E: T.19, D.70 Ligand excluded by PLIP

2 x 32J: 2-chloro-4-hydroxy-3-(2'-hydroxybiphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile(Non-covalent)

32J.6: 17 residues within 4Å: Chain A: V.13, L.20, G.21, K.31, K.33, I.48, N.50, K.53, D.90, F.92 Chain B: V.15, R.17, T.40, R.41, D.42, V.47, I.49 10 PLIP interactions: 3 interactions with chain B, 7 interactions with chain A Hydrophobic interactions: B:T.40, B:V.47, A:V.13, A:K.33 pi-Cation interactions: B:R.17, A:K.33 Hydrogen bonds: A:G.21, A:K.31, A:N.50, A:D.90 32J.17: 17 residues within 4Å: Chain D: V.13, L.20, G.21, K.31, K.33, I.48, N.50, K.53, D.90, F.92 Chain E: V.15, R.17, T.40, R.41, D.42, V.47, I.49 10 PLIP interactions: 7 interactions with chain D, 3 interactions with chain E Hydrophobic interactions: D:V.13, D:K.33, E:T.40, E:V.47 Hydrogen bonds: D:G.21, D:K.31, D:N.50, D:D.90 pi-Cation interactions: D:K.33, E:R.17

4 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)

AMP.8: 14 residues within 4Å: Chain C: H.150, T.199, I.203, A.204, V.224, S.225, A.226, P.228, H.297, R.298, I.311, S.313, S.315, D.316 13 PLIP interactions: 13 interactions with chain C Hydrogen bonds: C:T.199, C:A.204, C:A.204, C:S.225, C:S.225, C:S.225, C:S.225, C:R.298, C:S.313, C:S.315, C:D.316 Salt bridges: C:H.150, C:H.297 AMP.9: 13 residues within 4Å: Chain C: R.69, K.169, I.239, S.241, F.243, D.244, R.268, V.275, L.276, V.296, H.297, R.298, L.299 10 PLIP interactions: 10 interactions with chain C Hydrogen bonds: C:S.241, C:D.244, C:R.268, C:L.276, C:L.276, C:H.297, C:R.298 Salt bridges: C:R.69, C:K.169, C:R.298 AMP.19: 14 residues within 4Å: Chain F: H.150, T.199, I.203, A.204, V.224, S.225, A.226, P.228, H.297, R.298, I.311, S.313, S.315, D.316 14 PLIP interactions: 14 interactions with chain F Hydrogen bonds: F:T.199, F:T.199, F:A.204, F:A.204, F:S.225, F:S.225, F:S.225, F:S.225, F:R.298, F:S.313, F:S.315, F:D.316 Salt bridges: F:H.150, F:H.297 AMP.20: 13 residues within 4Å: Chain F: R.69, K.169, I.239, S.241, F.243, D.244, R.268, V.275, L.276, V.296, H.297, R.298, L.299 10 PLIP interactions: 10 interactions with chain F Hydrogen bonds: F:S.241, F:D.244, F:R.268, F:L.276, F:L.276, F:H.297, F:R.298 Salt bridges: F:R.69, F:K.169, F:R.298

2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.10: 15 residues within 4Å: Chain C: R.69, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153, K.242 13 PLIP interactions: 13 interactions with chain C Hydrogen bonds: C:I.87, C:T.88, C:D.89, C:Y.120, C:Y.120, C:V.129, C:H.150, C:R.151, C:R.151 Salt bridges: C:R.69, C:H.150, C:H.150, C:K.242 ADP.21: 15 residues within 4Å: Chain F: R.69, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153, K.242 13 PLIP interactions: 13 interactions with chain F Hydrogen bonds: F:T.86, F:I.87, F:T.88, F:D.89, F:Y.120, F:V.129, F:H.150, F:R.151, F:R.151 Salt bridges: F:R.69, F:H.150, F:H.150, F:K.242

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.11: 3 residues within 4Å: Chain C: R.151, T.167, K.169 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:T.167 Salt bridges: C:R.151, C:K.169 SO4.22: 3 residues within 4Å: Chain F: R.151, T.167, K.169 2 PLIP interactions: 2 interactions with chain F Salt bridges: F:R.151, F:K.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Calabrese, M.F. et al., Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms. Structure (2014)

Release Date

2014-08-06

Peptides

5'-AMP-activated protein kinase catalytic subunit alpha-1: AD
5'-AMP-activated protein kinase subunit beta-1: BE
5'-AMP-activated protein kinase subunit gamma-1: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
A

B
B

E
B

C
C

F
C

5'-AMP-activated protein kinase catalytic subunit alpha-1

5'-AMP-activated protein kinase subunit beta-1

5'-AMP-activated protein kinase subunit gamma-1

Related Entries With Identical Sequence